Funding events
Round dates, stages and disclosed amounts provide a structured chronology of company financing.
Funding intelligence
Understand where capital is moving, which companies it is backing and what financing activity means in the wider evidence context.
Why it matters
Headline funding totals can obscure more than they reveal. A market can look stable while capital concentrates into fewer companies, larger rounds or a narrow set of categories. A company can raise substantial capital without equivalent clinical or commercial progress.
HealthTech Alpha connects financing events to the companies, investors, markets and other signals around them. This supports analysis of funding history and market direction without treating capital raised as a standalone measure of quality.
The record model
Each signal remains linked to the entities and context needed to interpret it.
Round dates, stages and disclosed amounts provide a structured chronology of company financing.
Connected investor records show who participated and where investment relationships recur.
Funding events remain linked to the underlying company, product and market context.
Comparable records support trend analysis by period, geography, category, stage and other defined cohorts.
Analysis workflow
Define the geography, solution, stage and period that make comparisons meaningful.
Review rounds on a consistent basis and separate individual financing events from aggregate capital.
Examine whether apparent growth is broad-based or driven by a small number of large transactions.
Interpret funding alongside partnerships, clinical evidence, company maturity and market activity.
Method and governance
Financing is recorded as dated activity rather than a single undifferentiated company total.
Trends use defined inclusion rules so periods and markets can be compared on the same basis.
Companies and investors are resolved across events to reduce double counting and reveal recurring relationships.
Point-in-time records support analysis of what was visible at a particular stage of the market.
Decision use cases
Measure deployment, concentration and stage shifts across digital health markets.
Place a company financing history in the context of peers and category activity.
Identify categories attracting durable capital rather than isolated headline rounds.
Track follow-on financing and changes in capital momentum across a selected cohort.
Related analysis
Explore Galen Growth research built from the same structured intelligence foundation.
FAQ
Funding analysis can be scoped by time period, geography, company, solution category, financing stage and investor context, subject to the fields available for each record.
The platform distinguishes disclosed information from unavailable terms. Undisclosed activity should not be treated as equivalent to a round with a verified amount.
No. Funding can indicate market conviction and resources, but it is interpreted alongside clinical evidence, partnerships, maturity and other signals.
HealthTech Alpha intelligence
See it in your decision context
We will show how HealthTech Alpha structures the relevant records, comparisons and evidence trail.